Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsila Zuckerman

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
Rheumatology (Oxford, England)|September 6, 2023
Outcomes in progressive systemic sclerosis treated with autologous hematopoietic stem cell transplantation compared with combination therapyShiri Keret, Israel Henig, Tsila Zuckerman, et al.
American Journal of Blood Research|September 3, 2013
Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC)Igor B Resnick, Claudine Barkats, Michael Y Shapira, et al.
Rheumatology (Oxford, England)|November 1, 2024
Neutrophil-to-lymphocyte ratio as a biomarker for clinical response after autologous haematopoietic stem cell transplantation in systemic sclerosisShiri Keret, Lisa Kaly, George Schett, et al.
American Journal of Hematology|November 21, 2018
Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remissionXavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.
Cancer|June 22, 2019
Individualized prediction of leukemia-free survival after autologous stem cell transplantation in acute myeloid leukemiaRoni Shouval, Myriam Labopin, Norbert C Gorin, et al.
Blood|May 31, 2012
Cell lineage analysis of acute leukemia relapse uncovers the role of replication-rate heterogeneity and microsatellite instabilityLiran I Shlush, Noa Chapal-Ilani, Rivka Adar, et al.
Bone Marrow Transplantation|May 11, 2020
Risk stratification using FLT3 and NPM1 in acute myeloid leukemia patients autografted in first complete remissionRoni Shouval, Myriam Labopin, David Bomze, et al.
Blood Advances|November 27, 2019
BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a studyTsila Zuckerman, Ron Ram, Luiza Akria, et al.
American Journal of Hematology|October 6, 2015
Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the "3 + 7" induction regimen for acute myeloid leukemiaYishai Ofran, Ronit Leiba, Chezi Ganzel, et al.
American Journal of Infection Control|November 27, 2013
Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: A prospective controlled trialIlana Oren, Hannah Sprecher, Renato Finkelstein, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
Rheumatology (Oxford, England)|September 6, 2023
Outcomes in progressive systemic sclerosis treated with autologous hematopoietic stem cell transplantation compared with combination therapyShiri Keret, Israel Henig, Tsila Zuckerman, et al.
American Journal of Blood Research|September 3, 2013
Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC)Igor B Resnick, Claudine Barkats, Michael Y Shapira, et al.
Rheumatology (Oxford, England)|November 1, 2024
Neutrophil-to-lymphocyte ratio as a biomarker for clinical response after autologous haematopoietic stem cell transplantation in systemic sclerosisShiri Keret, Lisa Kaly, George Schett, et al.
American Journal of Hematology|November 21, 2018
Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remissionXavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.
Cancer|June 22, 2019
Individualized prediction of leukemia-free survival after autologous stem cell transplantation in acute myeloid leukemiaRoni Shouval, Myriam Labopin, Norbert C Gorin, et al.
Blood|May 31, 2012
Cell lineage analysis of acute leukemia relapse uncovers the role of replication-rate heterogeneity and microsatellite instabilityLiran I Shlush, Noa Chapal-Ilani, Rivka Adar, et al.
Bone Marrow Transplantation|May 11, 2020
Risk stratification using FLT3 and NPM1 in acute myeloid leukemia patients autografted in first complete remissionRoni Shouval, Myriam Labopin, David Bomze, et al.
Blood Advances|November 27, 2019
BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a studyTsila Zuckerman, Ron Ram, Luiza Akria, et al.
American Journal of Hematology|October 6, 2015
Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the "3 + 7" induction regimen for acute myeloid leukemiaYishai Ofran, Ronit Leiba, Chezi Ganzel, et al.
American Journal of Infection Control|November 27, 2013
Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: A prospective controlled trialIlana Oren, Hannah Sprecher, Renato Finkelstein, et al.
Pageof 11